AudioStocks.com Interviews Leading Executives

SAN DIEGO, July 25, 2005 (PRIMEZONE) -- AudioStocks.com is pleased to announce that it has posted exclusive interviews from leading executives from the following companies on the www.AudioStocks.com website: International Monetary Systems Limited (OTCBB:INLM), ProtoKinetix, Inc. (OTCBB:PKTX) and Telzuit Medical Technologies, Inc./Taylor Madison (Pink Sheets:TMDN).

International Monetary Systems Ltd.: CEO Don Mardak shares his thoughts about successful business strategies and the increasing popularity of the cashless system for business.

ProtoKinetix: Dr. Todd discusses ProtoKinetix's recently announced AFGP test results as well as a new collaboration with The Etablissment Francais du Sang-Alsace (EFS), a premier research facility in the field of hematology.

Telzuit Medical Technologies: Michael Vosch, Senior Vice President of Product Development of Taylor Madison and Telzuit, discussed the patent application that was just filed with the U.S. Patent and Trademark Office for an innovative Wireless Home Sleep Apnea Test.

About AudioStocks.com

AudioStocks.com is an Internet-based publishing platform designed to create, catalogue, distribute and make functional, financial content and data related to that content. AudioStocks.com solutions generate rich media exposure for public and private companies, industry groups and investment professionals through the AudioStocks.com proprietary software platform. AudioStocks.com software is primarily used to: (1) facilitate executive and company participation in industry and event-based roundtables and conferences; (2) create and distribute audio-based content related to a particular private or public company or an industry in which a company conducts business; (3) append interview-related and other rich media content to traditional press releases; and (4) for registered investment professionals only, to add interview-based audio content to financial research. AudioStocks.com content is distributed to millions of individuals online and over 30,000 financial professionals, including North American and international buy-side analysts, investment research professionals and portfolio managers. All content is copyrighted to protect licensing partners.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887